NPM1 and acute myeloid leukemia: Data from a Mexican AML population suggested, CEBPA, RUNX1 GATA2, TET2, AML1‐ETO, U2AF1, ASXL1, and KIT are enriched in that population, whereas FLT3‐ITD, DNMT3A, NPM1, and IDH2 were under‐represented [14].